查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017783

伴侶動物再生醫學市場規模、佔有率和趨勢分析報告：按產品、動物、應用、最終用途、地區和細分市場分類（2026-2033 年）

Companion Animal Regenerative Medicine Market Size, Share & Trends Analysis Report By Product (Stem Cells, Platelet-Rich Plasma ), By Animal, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

伴侶動物再生醫學市場概述

全球伴侶動物再生醫學市場預計到 2025 年價值 11.4 億美元，預計到 2033 年將達到 22.8 億美元，2026 年至 2033 年的複合年成長率為 9.38%。

由於幹細胞工程和轉化研究領域的技術突破不斷增加，先進治療方法的商業性應用和獸醫需求不斷成長，以及人們對伴侶動物再生醫學的認知和需求不斷擴大，該市場正在顯著成長。

幹細胞生物學和再生工程領域的技術進步顯著提升了伴侶動物醫療保健的治療能力。細胞培養系統、分化控制和功能性組織生成的創新，推動了高度專業化的再生醫學的發展。此外，將幹細胞分化為功能性心肌細胞和其他組織特異性細胞的突破性技術，拓展了其在疾病建模、藥物測試和精準醫療等領域的應用範圍。例如，2025年11月，大阪市立大學的研究人員開發了一種新型培養基，能夠可靠地將犬隻誘導多能幹細胞（iPS細胞）分化為功能性、收縮性心肌細胞，從而推進了再生醫學的研究及其在獸藥研發中的應用。這些進展提高了治療的可靠性、可重複性和擴充性，增強了其在獸醫學領域從研究到臨床實踐的應用。此外，利用人類和動物疾病之間的相似性開展的轉化研究正在加速創新進程，提高治療效果，並為再生醫學在多種伴侶動物疾病領域的應用提供長期支持。

此外，伴侶動物再生醫學產業的發展正受到創新治療平台在獸醫實踐中日益廣泛的商業性應用所推動。認證治療中心數量的增加和服務網路的擴展，提高了獲得先進再生醫學解決方案的途徑。同時，針對多種動物的治療方案數量的增加，也反映了臨床應用的加速和運作擴充性。此外，許多獸醫診所正在將再生醫學技術納入腫瘤、整形外科損傷和慢性退化性疾病的治療方案中。 2025年1月的報告指出，密蘇里大學的一項臨床試驗使用CAR-T細胞療法治療犬淋巴瘤，有效減輕了腫瘤腫脹，展現了該療法在推進動物癌症治療方面的巨大潛力。業界致力於提高治療的成本效益、加強臨床結果的記錄以及擴大獸醫培訓項目，這些舉措進一步推動了這一趨勢的發展。

此外，獸醫和寵物飼主對再生醫學的認知不斷提高，正在推動市場擴張。幹細胞療法作為一種有效替代療法，在傳統治療方法有其限制的疾病領域日益受到認可，這促進了其應用。同樣，教育活動的活性化、臨床病例報告的增加以及積極的治療結果，也增強了人們對再生醫學方法的信心。此外，對能夠改善伴侶動物復健、功能和生活品質的先進微創治療方法的需求不斷成長，也加速了再生醫學的普及。而且，提供再生醫學手術的專業獸醫中心數量不斷增加，以及寵物飼主願意投資於先進護理，都在推動市場需求的持續成長，並支持再生醫學解決方案的更廣泛商業化。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 定價模式分析
  • 疾病盛行率分析
  • 科技情勢
  • 2025年主要物種和主要國家的動物數量估計
  • 市場分析工具

第4章：伴侶動物再生醫學市場：產品具體估算與趨勢分析

  • 伴侶動物再生醫學市場：基於產品的波動分析
  • 伴侶動物再生醫學市場：按產品分類的估算與預測，2021-2033年
  • 幹細胞
  • 富血小板血漿（PRP）
  • 其他產品

第5章：伴侶動物再生醫學市場：依動物種類分類的估算與趨勢分析

  • 伴侶動物再生醫學市場：依動物種類分析市場波動
  • 伴侶動物再生醫學市場：按動物種類分類的估算與預測，2021-2033年
  • 狗
  • 貓
  • 馬
  • 其他

第6章：伴侶動物再生醫學市場：按應用領域分類的估算與趨勢分析

  • 伴侶動物再生醫學市場：基於應用的波動分析
  • 伴侶動物再生醫學市場：按應用領域分類的估算與預測，2021-2033年
  • 整形外科
  • 創傷和創傷護理
  • 其他用途

第7章：伴侶動物再生醫學市場：依最終用途分類的估算與趨勢分析

  • 伴侶動物再生醫學市場：依最終用途分類的波動分析
  • 伴侶動物再生醫學市場：依最終用途分類的估算與預測，2021-2033年
  • 動物醫院
  • 獸醫研究所

第8章：伴侶動物再生醫學市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • UAE
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第9章 競爭情勢

  • 參與企業的分類
    • 市場領導
    • 新興企業
  • 2025年市佔率及估值分析（熱圖分析）
  • 公司簡介
    • Boehringer Ingelheim International GmbH
    • Zoetis Services LLC
    • Dechra
    • Integra Lifesciences
    • Vetherapy
    • Vetstem, Inc.
    • Ardent
    • Enso Discoveries
    • Animal Cell Therapies, Inc.
    • Vetbiologics
    • Medrego
    • Vivos Inc（IsoPet）
Product Code: GVR-4-68040-871-3

Companion Animal Regenerative Medicine Market Summary

The global companion animal regenerative medicine market size was estimated at USD 1.14 billion in 2025 and is projected to reach USD 2.28 billion by 2033, growing at a CAGR of 9.38% from 2026 to 2033. The market is growing significantly due to increasing technological breakthroughs in stem cell engineering and translational research, rising commercial adoption and veterinary demand for advanced therapies and growing awareness and demand for regenerative medicine in companion animals.

Technological progress in stem cell biology and regenerative engineering is significantly advancing therapeutic capabilities in companion animal healthcare. Some of the innovations such as in cell culture systems, differentiation control, and functional tissue generation are enabling the development of highly specialized regenerative treatments. Besides this, breakthroughs allowing stem cells to transform into functional cardiac and other tissue-specific cells are expanding applications in disease modeling, drug testing, and precision therapies. For instance, in November 2025, researchers at Osaka Metropolitan University developed a new culture medium enabling canine iPS stem cells to reliably differentiate into functional, contracting heart muscle cells, advancing regenerative medicine research and veterinary drug discovery applications. These advancements improve treatment reliability, reproducibility, and scalability, strengthening clinical translation from research to veterinary practice. Moreover, translational research leveraging similarities between human and animal diseases is accelerating innovation pipelines, enhancing therapeutic effectiveness, and supporting long-term growth of regenerative medicine applications across multiple companion animal disease areas.

Moreover, the companion animal regenerative medicine industry is being propelled by increasing commercial deployment of innovative therapeutic platforms across veterinary practices. The growing numbers of certified treatment centers and expanding service networks are improving accessibility to advanced regenerative solutions. Besides this, the rising volume of administered therapies across multiple animal species reflects accelerating clinical adoption and operational scalability. In addition, veterinary institutions are integrating regenerative procedures into treatment protocols for oncology, orthopedic injuries, and chronic degenerative conditions in large number. According to a report of January 2025, a University of Missouri clinical trial used CAR T-cell therapy to treat lymphoma in a dog, reducing tumor swelling and showing promising potential for advancing cancer treatment in animals. This trend is further supported by industry initiatives focused on improving treatment affordability, enhancing clinical outcomes documentation, and expanding practitioner training programs.

Furthermore, rising awareness among veterinarians and pet owners regarding regenerative therapies is increasing significantly, driving market expansion. The growing recognition of stem cell based treatments as viable alternatives for conditions where conventional therapies are limited is encouraging adoption. Similarly, rising education efforts, clinical case reporting, and positive treatment outcomes are strengthening confidence in regenerative approaches. Besides this, increasing demand for advanced, minimally invasive treatment options that improve recovery, functionality, and quality of life in companion animals is accelerating its adoption. Moreover, expanding availability of specialized veterinary centers offering regenerative procedures and the growing willingness of pet owners to invest in advanced care are reinforcing sustained market demand and supporting broader commercialization of regenerative medicine solutions.

Global Companion Animal Regenerative Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the companion animal regenerative medicine market report based on product, animal, application, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Stem Cells
  • Platelet-Rich Plasma (PRP)
  • Other Products
  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Dogs
  • Cats
  • Horses
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Orthopedics
  • Trauma/Wound Care
  • Other Applications
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Clinics & Hospitals
  • Veterinary Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Commodity Flow Analysis
    • 1.7.2. Model 2: Bottom-Up Analysis
    • 1.7.3. Model 3 Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Technological Breakthroughs in Stem Cell Engineering and Translational Research
      • 3.2.1.2. Rising Commercial Adoption and Veterinary Demand for Advanced Therapies
      • 3.2.1.3. Growing Awareness and Demand for Regenerative Medicine in Companion Animals
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost and Limited Reimbursement for Advanced Therapies
      • 3.2.2.2. Regulatory Challenges and Safety Concerns in Veterinary Applications
    • 3.2.3. Market Opportunity Analysis
  • 3.3. Pricing Model Analysis
  • 3.4. Disease Prevalence Analysis
  • 3.5. Technology Landscape
  • 3.6. Estimated Animal Population by Key Species & Key Countries, 2025
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Companion Animal Regenerative Medicine Market: Product Estimates & Trend Analysis

  • 4.1. Companion Animal Regenerative Medicine Market, By Product: Segment Dashboard
  • 4.2. Companion Animal Regenerative Medicine Market, By Product Movement Analysis
  • 4.3. Companion Animal Regenerative Medicine Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 4.4. Stem Cells
    • 4.4.1. Stem Cells Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 4.5. Platelet-Rich Plasma (PRP)
    • 4.5.1. Platelet-Rich Plasma (PRP) Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 4.6. Other Products
    • 4.6.1. Other Products Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 5. Companion Animal Regenerative Medicine Market: By Animal Estimates & Trend Analysis

  • 5.1. Companion Animal Regenerative Medicine Market, By Animal: Segment Dashboard
  • 5.2. Companion Animal Regenerative Medicine Market, By Animal Movement Analysis
  • 5.3. Companion Animal Regenerative Medicine Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
  • 5.4. Dogs
    • 5.4.1. Dogs Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 5.5. Cats
    • 5.5.1. Cats Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 5.6. Horses
    • 5.6.1. Horses Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 6. Companion Animal Regenerative Medicine Market: By Application Estimates & Trend Analysis

  • 6.1. Companion Animal Regenerative Medicine Market, By Application: Segment Dashboard
  • 6.2. Companion Animal Regenerative Medicine Market, By Application Movement Analysis
  • 6.3. Companion Animal Regenerative Medicine Market Estimates & Forecasts, by Application, 2021 to 2033 (USD Million)
  • 6.4. Orthopedics
    • 6.4.1. Orthopedics Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.5. Trauma/Wound Care
    • 6.5.1. Trauma/Wound Care Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.6. Other Applications
    • 6.6.1. Other Applications Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. Companion Animal Regenerative Medicine Market: By End Use Estimates & Trend Analysis

  • 7.1. Companion Animal Regenerative Medicine Market, By End Use: Segment Dashboard
  • 7.2. Companion Animal Regenerative Medicine Market, By End Use Movement Analysis
  • 7.3. Companion Animal Regenerative Medicine Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Veterinary Clinics & Hospitals
    • 7.4.1. Veterinary Clinics & Hospitals Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.5. Veterinary Research Institutes
    • 7.5.1. Veterinary Research Institutes Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Companion Animal Regenerative Medicine Market: By Regional Estimates & Trend Analysis

  • 8.1. Region Market Dashboard
  • 8.2. Region Market Share Analysis, 2025 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Boehringer Ingelheim International GmbH
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product/Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Zoetis Services LLC
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product/Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Dechra
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product/Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Integra Lifesciences
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product/Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Vetherapy
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product/Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Vetstem, Inc.
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product/Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Ardent
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product/Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Enso Discoveries
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product/Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Animal Cell Therapies, Inc.
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product/Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Vetbiologics
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product/Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Medrego
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product/Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Vivos Inc (IsoPet)
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product/Service Benchmarking
      • 9.3.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
  • Table 4 Global Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 5 Global Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 6 Global Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 7 Global Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 10 North America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 11 North America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 12 North America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 15 U.S. Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 16 U.S. Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 19 Canada Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 20 Canada Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 23 Mexico Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 24 Mexico Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 28 Europe Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 29 Europe Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 31 UK Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 32 UK Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 33 UK Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 36 Germany Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 37 Germany Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 38 France Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 39 France Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 40 France Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 41 France Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 44 Italy Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 45 Italy Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 48 Spain Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 49 Spain Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Denmark Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 51 Denmark Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 52 Denmark Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 53 Denmark Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 56 Sweden Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 57 Sweden Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 58 Norway Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 59 Norway Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 60 Norway Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 61 Norway Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 68 Japan Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 69 Japan Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 70 Japan Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 71 China Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 72 China Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 73 China Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 74 China Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 75 India Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 76 India Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 77 India Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 78 India Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 80 Australia Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 81 Australia Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 82 Australia Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 84 Thailand Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 85 Thailand Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 86 Thailand Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 88 South Korea Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 89 South Korea Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 90 South Korea Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 94 Latin America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 95 Latin America Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 98 Brazil Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 99 Brazil Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 102 Argentina Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 103 Argentina Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 111 South Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 112 South Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 113 UAE Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 114 UAE Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 115 UAE Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 116 UAE Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 117 Saudi Arabia Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 118 Saudi Arabia Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 119 Saudi Arabia Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 120 Saudi Arabia Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 125 Qatar Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 126 Qatar Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 127 Qatar Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 128 Qatar Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 129 Oman Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 130 Oman Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 131 Oman Companion Animal Regenerative Medicine Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 132 Oman Companion Animal Regenerative Medicine Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value Chain-Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-Up Approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent Market Outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary Market Outlook, 2025 (USD Billion)
  • Fig. 16 Companion Animal Regenerative Medicine Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Companion Animal Regenerative Medicine Market: Product Outlook and Key Takeaways
  • Fig. 20 Companion Animal Regenerative Medicine Market: Product Movement Analysis
  • Fig. 21 Stem Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Platelet-Rich Plasma (PRP) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Other Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Companion Animal Regenerative Medicine Market: Animal Outlook and Key Takeaways
  • Fig. 25 Companion Animal Regenerative Medicine Market: Animal Movement Analysis
  • Fig. 26 Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Horses Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Companion Animal Regenerative Medicine Market: Application Outlook and Key Takeaways
  • Fig. 31 Companion Animal Regenerative Medicine Market: Application Movement Analysis
  • Fig. 32 Orthopedics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Trauma/Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Other Applications Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Companion Animal Regenerative Medicine Market: End Use Outlook and Key Takeaways
  • Fig. 36 Companion Animal Regenerative Medicine Market: End Use Movement Analysis
  • Fig. 37 Veterinary Clinics & Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Veterinary Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Regional Marketplace: Key Takeaways
  • Fig. 40 North America Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021-2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 U.S. Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Europe Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Germany Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 China Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 India Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Australia Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Thailand Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 South Korea Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Latin America Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Brazil Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Argentina Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 MEA Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 South Africa Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 UAE Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Saudi Arabia Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Kuwait Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Qatar Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Oman Companion Animal Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)